McKesson (NYSE:MCK) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of McKesson (NYSE:MCK) from a hold rating to a buy rating in a research note issued to investors on Sunday morning.

Several other analysts have also recently weighed in on MCK. Barclays raised their price target on McKesson from $960.00 to $1,050.00 and gave the company an “overweight” rating in a report on Wednesday, February 18th. Zacks Research cut shares of McKesson from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 25th. Leerink Partners reaffirmed an “outperform” rating and issued a $1,085.00 target price on shares of McKesson in a research note on Thursday, March 5th. Morgan Stanley reiterated an “overweight” rating and set a $966.00 target price on shares of McKesson in a research report on Thursday, January 29th. Finally, TD Cowen boosted their price target on shares of McKesson from $1,000.00 to $1,012.00 and gave the stock a “buy” rating in a research note on Thursday, February 5th. Thirteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, McKesson currently has an average rating of “Moderate Buy” and a consensus price target of $960.93.

McKesson Price Performance

MCK opened at $881.01 on Friday. The firm has a market capitalization of $107.91 billion, a P/E ratio of 25.34, a price-to-earnings-growth ratio of 1.41 and a beta of 0.38. McKesson has a one year low of $637.00 and a one year high of $999.00. The company has a fifty day moving average price of $905.89 and a 200-day moving average price of $837.19.

McKesson (NYSE:MCK) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. The company had revenue of $106.16 billion for the quarter, compared to the consensus estimate of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm’s revenue was up 11.4% compared to the same quarter last year. During the same quarter last year, the business posted $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, analysts expect that McKesson will post 32.77 earnings per share for the current year.

McKesson Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be given a dividend of $0.82 per share. The ex-dividend date is Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. McKesson’s dividend payout ratio is 9.43%.

Insider Activity at McKesson

In related news, EVP Thomas L. Rodgers sold 276 shares of the business’s stock in a transaction that occurred on Monday, January 5th. The stock was sold at an average price of $816.18, for a total value of $225,265.68. Following the completion of the sale, the executive vice president owned 2,268 shares in the company, valued at $1,851,096.24. The trade was a 10.85% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Maria Martinez sold 349 shares of the company’s stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $939.87, for a total value of $328,014.63. Following the completion of the sale, the director directly owned 301 shares of the company’s stock, valued at approximately $282,900.87. This represents a 53.69% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 3,868 shares of company stock worth $3,743,820 in the last quarter. 0.08% of the stock is owned by company insiders.

Institutional Investors Weigh In On McKesson

A number of institutional investors have recently made changes to their positions in the business. GGM Financials LLC purchased a new stake in McKesson during the third quarter valued at about $25,000. University of Texas Texas AM Investment Management Co. purchased a new position in shares of McKesson in the fourth quarter worth about $25,000. Swiss RE Ltd. purchased a new position in shares of McKesson in the fourth quarter worth about $26,000. State of Wyoming bought a new stake in shares of McKesson in the 2nd quarter valued at about $29,000. Finally, Hopwood Financial Services Inc. bought a new stake in shares of McKesson in the 3rd quarter valued at about $31,000. Hedge funds and other institutional investors own 85.07% of the company’s stock.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.